Advances in the Genetics of Hypertension: The Effect of Rare Variants

Area of Science:

• Genetics
• Cardiovascular Disease Research
• Genomics

Background:

• Hypertension remains a significant global health issue, causing millions of deaths annually.
• Essential hypertension is a multifactorial condition with a heritability of 30-50%, influenced by both genetic and environmental factors.
• Genome-Wide Association Studies (GWAS) have identified common variants but explain only a small fraction of hypertension's genetic variance.

Purpose of the Study:

• To review advances in detecting novel rare genetic variants associated with hypertension.
• To discuss emerging statistical methods for analyzing rare variants in complex diseases.
• To highlight the importance of functional studies and consortia for validating rare variants and their clinical relevance.

Main Methods:

• Review of current literature on rare variant detection in hypertension.
• Discussion of Next-Generation Sequencing and exome chip technologies.
• Analysis of recent statistical approaches for rare variant association testing.

Main Results:

• Genome-Wide Association Studies (GWAS) have identified common variants contributing minimally (2-3%) to hypertension's genetic variance.
• Rare variants, undetectable by GWAS, are increasingly discovered using advanced sequencing technologies.
• New statistical tests are being developed to effectively analyze the impact of these rare variants.

Conclusions:

• Rare genetic variants represent a significant portion of the missing heritability in hypertension.
• Further research, including large-scale replication and functional studies, is crucial for understanding the role of rare variants.
• Identifying novel genes and pathways through rare variant analysis may lead to improved patient stratification and personalized antihypertensive treatments.